Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshimasa Koshimizu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Yakushigaku Zasshi|October 3, 2014
[Chapter 3. Transitions in clinical trials and appropriate use of drugs in Japan (1980-2010)]Toshimasa Koshimizu
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 9, 2010
[Development and analyses of evaluation criteria for meta-analysis-relationship between renin-angiotensin system inhibitor and diabetes mellitus]Hisashi Iijima, Tomoka Osumi, Toshimasa Koshimizu
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 3, 2007
Objective evaluation of generic-specific drug informationHisashi Iijima, Toshimasa Koshimizu, Makoto Shiragami
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 1, 2004
Objective evaluation of generic drug informationHisashi Iijima, Miwako Kamei, Toshimasa Koshimizu, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 6, 2005
[Evaluation of information for generic drugs based on importance and necessity]Hisashi Iijima, Miwako Kamei, Toshimasa Koshimizu, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 24, 2003
[Calculation of drug information necessity factor of generic drugs]Hisashi Iijima, Teruyo Kurosaki, Miwako Kamei, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Yakushigaku Zasshi|October 3, 2014
[Chapter 3. Transitions in clinical trials and appropriate use of drugs in Japan (1980-2010)]Toshimasa Koshimizu
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 9, 2010
[Development and analyses of evaluation criteria for meta-analysis-relationship between renin-angiotensin system inhibitor and diabetes mellitus]Hisashi Iijima, Tomoka Osumi, Toshimasa Koshimizu
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 3, 2007
Objective evaluation of generic-specific drug informationHisashi Iijima, Toshimasa Koshimizu, Makoto Shiragami
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 1, 2004
Objective evaluation of generic drug informationHisashi Iijima, Miwako Kamei, Toshimasa Koshimizu, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 6, 2005
[Evaluation of information for generic drugs based on importance and necessity]Hisashi Iijima, Miwako Kamei, Toshimasa Koshimizu, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 24, 2003
[Calculation of drug information necessity factor of generic drugs]Hisashi Iijima, Teruyo Kurosaki, Miwako Kamei, et al.
Pageof 1